{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:28:38Z","timestamp":1757543318030},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1979,1,1]],"date-time":"1979-01-01T00:00:00Z","timestamp":283996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1979]]},"DOI":"10.1007\/bf00496062","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T17:11:29Z","timestamp":1100538689000},"page":"197-200","source":"Crossref","is-referenced-by-count":11,"title":["Modification of the behavioural effects of amphetamine by a GABA agonist in a primate species"],"prefix":"10.1007","volume":"64","author":[{"given":"R. M.","family":"Ridley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Scraggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. F.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.2042-7158.1965.tb07717.x","volume":"17","author":"A. Carlsson","year":"1965","unstructured":"Carlsson, A., Lindqvist, M., Dahlstr\ufffdm, A., Fuxe, K., Masuoka, D.: Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro. J. Pharmac. Pharmacol. 17, 521?523 (1965)","journal-title":"J. Pharmac. Pharmacol."},{"key":"CR2","series-title":"Advances in Neurology","volume-title":"Anatomy of the basal ganglia and related nuclei: A review","author":"M. B. Carpenter","year":"1976","unstructured":"Carpenter, M. B.: Anatomy of the basal ganglia and related nuclei: A review, Advances in Neurology, 14, R. Eldrige and S. Fahn, eds., New York: Raven 1976"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/BF01897450","volume":"22","author":"A. M. Ernst","year":"1966","unstructured":"Ernst, A. M., Smelik, P. G.: Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats. Experientia 22, 837?838 (1966)","journal-title":"Experientia"},{"key":"CR4","doi-asserted-by":"crossref","unstructured":"Frederiksen, P. K.: Baclofen in the treatment of schizophrenia. Lancet 1975I, 702?703","DOI":"10.1016\/S0140-6736(75)91819-X"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/265363a0","volume":"265","author":"M. Garcia-Munoz","year":"1977","unstructured":"Garcia-Munoz, M., Nicolaou, N. M., Tulloch, I. F., Wright, A. K., Arbuthnott, G. W.: Feedback loop or output pathway in striatonigral fibres? Nature 265, 363?365 (1977)","journal-title":"Nature"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0447.1976.tb00122.x","volume":"54","author":"N. C. Gulmann","year":"1976","unstructured":"Gulmann, N. C., Bahr, B., Andersen, B., Eliassen, H. M. M.: A double-blind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiat. Scand. 54, 287?293 (1976)","journal-title":"Acta Psychiat. Scand."},{"key":"CR7","doi-asserted-by":"crossref","unstructured":"Johnstone, F. C., Crow, T. J., Frith, C. D., Carney, M. W. P., Price, J. S.: Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1978I, 848?851","DOI":"10.1016\/S0140-6736(78)90193-9"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-2999(77)90143-1","volume":"46","author":"T. Ljundberg","year":"1977","unstructured":"Ljundberg, T., Ungerstedt, U.: Different behavioural patterns induced by apomorphine: evidence that the method of administration determines the behavioural response to the drug. Eur. J. Pharmacol. 46, 51?60 (1977)","journal-title":"Eur. J. Pharmacol."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00432845","volume":"56","author":"T. Ljundberg","year":"1978","unstructured":"Ljundberg, T., Ungerstedt, U.: Classification of neuroleptic drugs according to their ability to inhibit apomorphine induced gnawing and locomotion: evidence for principally different mechanisms of action. Psychopharmacology 56, 239?247 (1978)","journal-title":"Psychopharmacology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.2042-7158.1973.tb09995.x","volume":"25","author":"A. J. J. Pijnenburg","year":"1973","unstructured":"Pijnenburg, A. J. J., van Rossum, J. M.: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmacol. 25, 1003?1005 (1973)","journal-title":"J. Pharm. Pharmacol."},{"key":"CR11","first-page":"468","volume":"10","author":"E. Roberts","year":"1972","unstructured":"Roberts, E.: An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci. Res. Program Bull. 10, 468?481 (1972)","journal-title":"Neurosci. Res. Program Bull."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0024-3205(78)90414-9","volume":"22","author":"J. Scheel-Kr\ufffdger","year":"1978","unstructured":"Scheel-Kr\ufffdger, J., Christensen, A. V., Arnt, J.: Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: a complex GABA-dopamine interaction. Life Sci. 22, 75?84 (1978)","journal-title":"Life Sci."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/0024-3205(77)90250-8","volume":"21","author":"J. Scheel-Kr\ufffdger","year":"1977","unstructured":"Scheel-Kr\ufffdger, J., Cools, A. R., van Wel, P. M.: Muscimol, a GABA-agonist, injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility. Life Sci. 21, 1697?1702 (1977)","journal-title":"Life Sci."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1163\/156853971X00131","volume":"39","author":"E. Schi\ufffdrring","year":"1971","unstructured":"Schi\ufffdrring, E.: Amphetamine induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open field test with rats. Behaviour 39, 1?17 (1971)","journal-title":"Behaviour"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00426628","volume":"59","author":"P. R. Scraggs","year":"1978","unstructured":"Scraggs, P. R., Ridley, R. M.: Behavioural effects of amphetamine in a small primate: relative potencies of the d- and l-isomers. Psychopharmacology 59, 243?245 (1978)","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00426033","volume":"62","author":"P. R. Scraggs","year":"1979","unstructured":"Scraggs, P. R., Ridley, R. M.: The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset. Psychopharmacology 62, 41?45 (1979)","journal-title":"Psychopharmacology"},{"key":"CR17","first-page":"746","volume":"135","author":"C. A. Tamminga","year":"1979","unstructured":"Tamminga, C. A., Crayton, J. W., Chase, T. N.: Muscimol: GABA agonist therapy in schizophrenia. Am. J. Psychiat. 135, 746?747 (1979)","journal-title":"Am. J. Psychiat."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1176\/ajp.134.2.138","volume":"134","author":"D. P. Kammen van","year":"1977","unstructured":"van Kammen, D. P.: ?-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am. J. Psychiat. 134, 138?143 (1977)","journal-title":"Am. J. Psychiat."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0024-3205(78)90367-3","volume":"22","author":"J. L. Waddington","year":"1978","unstructured":"Waddington, J. L., Cross, A. J.: Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABAergic accumbal-ventral tegmental pathway. Life Sci. 22, 1011?1014 (1978)","journal-title":"Life Sci."}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00496062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00496062\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00496062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T12:29:37Z","timestamp":1554380977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00496062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1979]]}},"alternative-id":["BF00496062"],"URL":"https:\/\/doi.org\/10.1007\/bf00496062","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979]]}}}